XML 38 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Correction of Immaterial Errors To Prior Period Financial Statements (Tables)
9 Months Ended
Mar. 31, 2017
Accounting Changes and Error Corrections [Abstract]  
Schedule of Correction of Immaterial Errors to Prior Period Financial Statements
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
 
Three Months Ended March 31, 2016
 
As Reported
 
Adjustment
 
As Revised
Net sales
$
749,862

 
$
(13,199
)
 
$
736,663

Cost of sales
576,653

 
102

 
576,755

    Gross profit
173,209

 
(13,301
)
 
159,908

Selling, general and administrative expenses
93,915

 
(15,025
)
 
78,890

Amortization of acquired intangibles
4,586

 
(33
)
 
4,553

Acquisition related expenses, restructuring and integration charges
  and other
5,701

 
(384
)
 
5,317

    Operating income
69,007

 
2,141

 
71,148

Interest and other financing expense, net
6,920

 

 
6,920

Other (income)/expense, net
378

 

 
378

Gain on fire insurance recovery
(9,013
)
 
 
 
(9,013
)
Income before income taxes and equity in earnings of equity-
  method investees
70,722

 
2,141

 
72,863

Provision for income taxes
21,576

 
2,338

 
23,914

Equity in net income of equity-method investees
161

 

 
161

Net income
$
48,985

 
$
(197
)
 
$
48,788

 
 
 
 
 
 
Net income per common share:
 
 
 
 
 
    Basic
$
0.47

 
$

 
$
0.47

    Diluted
$
0.47

 
$

 
$
0.47

 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
    Basic
103,265

 
103,265

 
103,265

    Diluted
104,087

 
104,087

 
104,087


* Net income per common share may not add in certain periods due to rounding

















CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (CONTINUED)
 
Nine Months Ended March 31, 2016
 
As Reported
 
Adjustment
 
As Revised
Net sales
$
2,189,639

 
$
(41,812
)
 
$
2,147,827

Cost of sales
1,686,820

 
(3,043
)
 
1,683,777

    Gross profit
502,819

 
(38,769
)
 
464,050

Selling, general and administrative expenses
262,776

 
(39,355
)
 
223,421

Amortization/impairment of acquired intangibles
13,994

 
(98
)
 
13,896

Acquisition related expenses, restructuring and integration charges
  and other
11,852

 
(617
)
 
11,235

    Operating income
214,197

 
1,301

 
215,498

Interest and other financing expense, net
19,760

 
(73
)
 
19,687

Other (income)/expense, net
8,771

 
73

 
8,844

Gain on fire insurance recovery
(9,013
)
 

 
(9,013
)
Income before income taxes and equity in earnings of equity-
  method investees
194,679

 
1,301

 
195,980

Provision for income taxes
57,337

 
2,509

 
59,846

Equity in net income of equity-method investees
108

 

 
108

Net income
137,234

 
(1,208
)
 
136,026

 
 
 
 
 
 
Net income per common share:
 
 
 
 
 
    Basic
$
1.33

 
$
(0.01
)
 
$
1.32

    Diluted
$
1.32

 
$
(0.01
)
 
$
1.31

 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
    Basic
103,030

 
103,030

 
103,030

    Diluted
104,168

 
104,168

 
104,168


* Net income per common share may not add in certain periods due to rounding
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
 
 
Three Months Ended March 31, 2016
 
Nine Months Ended March 31, 2016
 
 
As Reported
 
Adjustment
 
As Revised
 
As Reported
 
Adjustment
 
As Revised
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 
$
48,985

 
$
(197
)
 
$
48,788

 
$
137,234

 
$
(1,208
)
 
$
136,026

 
 
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
 
$
(20,296
)
 
$
193

 
(20,103
)
 
$
(86,380
)
 
690

 
(85,690
)
Change in deferred gains (losses) on cash flow hedging instruments
 
(1,209
)
 

 
(1,209
)
 
(164
)
 

 
(164
)
Change in unrealized gain (loss) on available for sale investment
 
20

 

 
20

 
(112
)
 

 
(112
)
Total other comprehensive income (loss)
 
$
(21,485
)
 
$
193

 
$
(21,292
)
 
$
(86,656
)
 
$
690

 
$
(85,966
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Total comprehensive income
 
$
27,500

 
$
(4
)
 
$
27,496

 
$
50,578

 
$
(518
)
 
$
50,060

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
 
Nine Months Ended March 31, 2016
 
As Reported
 
Adjustment
 
As Revised
CASH FLOWS FROM OPERATING ACTIVITIES
 
 
 
 
 
Net income
$
137,234

 
$
(1,208
)
 
$
136,026

Adjustments to reconcile net income to net cash provided by (used in) operating
  activities:
 
 
 
 
 
  Depreciation and amortization
47,494

 
605

 
48,099

  Deferred income taxes
(9,377
)
 
(155
)
 
(9,532
)
  Equity in net income of equity-method investees
108

 

 
108

  Stock-based compensation
10,005

 

 
10,005

  Contingent consideration expense
1,511

 

 
1,511

  Gain on fire insurance recovery and other, net
(8,401
)
 

 
(8,401
)
  Other non-cash items, including unrealized currency (gains)/loss, net
7,403

 

 
7,403

Increase (decrease) in cash attributable to changes in operating assets and
  liabilities, net of amounts applicable to acquisitions:
 
 
 
 
 
  Accounts receivable
(29,201
)
 
(1,260
)
 
(30,461
)
  Inventories
(11,397
)
 
621

 
(10,776
)
  Other current assets
(650
)
 
22,691

 
22,041

  Other assets and liabilities
1,111

 

 
1,111

  Accounts payable and accrued expenses
(13,986
)
 
(21,294
)
 
(35,280
)
     Net cash provided by operating activities
$
131,854

 
$

 
$
131,854

SEGMENT NET SALES AND OPERATING INCOME (UNAUDITED)
 
Three months ended March 31, 2016
 
As Reported (1)
 
Adjustment
 
As Revised
Net Sales: 
 
 
 
 
 
United States
$
332,904

 
$
(7,520
)
 
$
325,384

United Kingdom
208,391

 
(2,231
)
 
$
206,160

Hain Pure Protein
113,643

 
(1,430
)
 
$
112,213

Rest of World
94,924

 
(2,018
)
 
$
92,906

 
$
749,862

 
$
(13,199
)
 
$
736,663

 
 
 
 
 
 
Operating Income:
 
 
 
 
 
United States
$
52,103

 
$
4,278

 
$
56,381

United Kingdom
16,217

 
(391
)
 
$
15,826

Hain Pure Protein
4,613

 
(2,186
)
 
$
2,427

Rest of World
8,641

 
(509
)
 
$
8,132

 
$
81,574

 
$
1,192

 
$
82,766

Corporate and Other
(12,567
)
 
949

 
(11,618
)
 
$
69,007

 
$
2,141

 
$
71,148


(1) The information previously reported for the three months ended March 31, 2016 has been adjusted to reflect the Company’s
new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment
Information, for additional details surrounding the formation of Cultivate.

 
Nine months ended March 31, 2016
 
As Reported (1)
 
Adjustment
 
As Revised
Net Sales: 
 
 
 
 
 
United States
$
970,368

 
$
(27,668
)
 
$
942,700

United Kingdom
567,971

 
(9,702
)
 
$
558,269

Hain Pure Protein
379,337

 
122

 
$
379,459

Rest of World
271,963

 
(4,564
)
 
$
267,399

 
$
2,189,639

 
$
(41,812
)
 
$
2,147,827

 
 
 
 
 
 
Operating Income:
 
 
 
 
 
United States
$
144,305

 
$
4,523

 
$
148,828

United Kingdom
45,189

 
(1,096
)
 
$
44,093

Hain Pure Protein
33,009

 
(1,931
)
 
$
31,078

Rest of World
17,910

 
(264
)
 
$
17,646

 
$
240,413

 
$
1,232

 
$
241,645

Corporate and Other
(26,216
)
 
69

 
(26,147
)
 
$
214,197

 
$
1,301

 
$
215,498


(1) The information previously reported for the nine months ended March 31, 2016 has been adjusted to reflect the Company’s
new operating and reporting structure effective in the first quarter of fiscal 2017. See Note 1, Business, and Note 16, Segment
Information, for additional details surrounding the formation of Cultivate.